Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Assistenzarzt/-ärztin, Klinik für Urologie
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
-
WiSe 2022
-
SoSe 2022
-
WiSe 2021
-
SoSe 2021
-
WiSe 2020
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinomaIn: Cancer Immunology, Immunotherapy, Jg. 74, 2025, Nr. 12, 370DOI (Open Access)
-
Comparison of MemoKath™ ureteral stent versus tumor ureteral stent : A single-center long-term analysisIn: Central European Journal of Urology, Jg. 78, 2025, Nr. 2, S. 237 – 243DOI (Open Access)
-
Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and their Prognostic Value in Radical ProstatectomyIn: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 3, S. 352 – 358
-
Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapyIn: The Journal of Pathology: Clinical Research, Jg. 11, 2025, Nr. 1, e70017DOI (Open Access)
-
Impact of Extended Versus Limited Lymph Node Dissection on Surgical Outcome, Recurrence Patterns and Survival After Radical CystectomyIn: Clinical Genitourinary Cancer, Jg. 23, 2025, Nr. 3, 102337
-
Lymphovascular Invasion is Predictive for Adjuvant Platinum Therapy Benefit in Urothelial Bladder CancerIn: Clinical Genitourinary Cancer, Jg. 23, 2025, Nr. 6, 102421DOI (Open Access)
-
Outcomes of surgical therapy for local recurrence and oligometastatic urothelial carcinoma of the bladder : 20 years of experience in a tertiary centerIn: Urologia Internationalis, Jg. 109, 2025, Nr. 4, S. 337 – 345
-
PSMA-Radioligandentherapie : State of the ArtIn: Die Urologie, Jg. 64, 2025, Nr. 10, S. 1093 – 1104
-
Radiopharmaceuticals in Prostate Cancer : General Considerations and Utility in Combination With EBRTIn: Seminars in Radiation Oncology, Jg. 35, 2025, Nr. 3, S. 463 – 473
-
Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancerIn: BJU International (BJUI), Jg. 136, 2025, Nr. 2, S. 297 – 305DOI (Open Access)
-
Temporal patterns of major postoperative events after radical cystectomy : Analysis of 90-day morbidityIn: World Journal of Urology, Jg. 43, 2025, Nr. 1, 111
-
Bricker versus Wallace ureteroileal anastomosis : A multi-institutional propensity score-matched analysisIn: International Journal of Urology, Jg. 31, 2024, Nr. 7, S. 813 – 818DOI (Open Access)
-
Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device : A single center experienceIn: Journal of Surgical Oncology, Jg. 129, 2024, Nr. 7, S. 1325 – 1331DOI (Open Access)
-
Neoadjuvante Therapie beim Höchst-Risiko ProstatakarzinomIn: Die Urologie, Jg. 63, 2024, Nr. 11, S. 1211 – 1212
-
Risk factors for ureteroenteric stricture after radical cystectomy and urinary diversion : A systematic reviewIn: Arab Journal of Urology, Jg. 22, 2024, Nr. 1, S. 61 – 69DOI (Open Access)
-
Short-Term Urinary Incontinence After Radical Prostatectomy Is Still Based on Patients' Age, Nerve-Sparing Approach, and Surgical-Experience, Despite the Higher-Use of Robotic Surgery in 2022 Compared to 2016 Real-World Results of a Large Rehabilitation Center in GermanyIn: Cancer Reports, Jg. 7, 2024, Nr. 12, e70092DOI, Online Volltext (Open Access)
-
The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadismIn: Scientific Reports, Jg. 14, 2024, Nr. 1, 28141DOI, Online Volltext (Open Access)
-
The impact of double-J ureteral stenting before radical cystectomy on the development of upper tract urothelial carcinomaIn: Minerva Urology and Nephrology, Jg. 76, 2024, Nr. 4, S. 442 – 451
-
18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in MenIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 4, S. 598 – 604DOI (Open Access)
-
Cumulative sum analysis (CUSUM) for evaluating learning curve (LC) of robotic-assisted laparoscopic partial nephrectomy (RALPN)In: Journal of Robotic Surgery, Jg. 17, 2023, Nr. 5, S. 2089 – 2098
-
Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy : A Prospective Randomized TrialIn: European Urology Oncology, Jg. 6, 2023, Nr. 1, S. 49 – 55
-
Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice : results of a multicentric, retrospective studyIn: Scientific Reports, Jg. 13, 2023, Nr. 1, 17378DOI (Open Access)
-
Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer : Answers from a Prospective RegistryIn: Cancers, Jg. 15, 2023, Nr. 20, 4933DOI (Open Access)
-
Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy SpecimensIn: European Urology Open Science, Jg. 54, 2023, S. 28 – 32DOI (Open Access)
-
Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy : a systematic review and meta-analysisIn: Cancer Immunology, Immunotherapy, Jg. 72, 2023, Nr. 5, S. 1061 – 1073DOI (Open Access)
-
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancerIn: Cancer Medicine, Jg. 12, 2023, Nr. 5, S. 5222 – 5232DOI, Online Volltext (Open Access)
-
Combining avelumab and stereotactic ablative body radiotherapy in metastatic castration-resistant prostate cancer : Efficacy and safety—phase II ICE-PACIn: Der Urologe, Jg. 61, 2022, Nr. 3, S. 301 – 303
-
Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric strictureIn: Langenbeck's Archives of Surgery, Jg. 407, 2022, Nr. 3, S. 1233 – 1240DOI (Open Access)
-
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial CarcinomaIn: Biomedicines, Jg. 10, 2022, Nr. 3, 698DOI, Online Volltext (Open Access)
-
High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial CarcinomaIn: Biomedicines, Jg. 10, 2022, Nr. 10, 2560DOI (Open Access)
-
Radiation Protection and Occupational Exposure on ⁶⁸Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted ProstatectomyIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 9, S. 1349 – 1356DOI (Open Access)
-
Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer : A Retrospective Analysis of a Single-Centre CohortIn: Urologia Internationalis, Jg. 106, 2022, S. 638 – 643
-
Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy : A Feasibility StudyIn: European Urology Oncology, Jg. 5, 2022, Nr. 3, S. 357 – 361DOI, Online Volltext (Open Access)
-
A new technological approach in diagnostic pathology : Mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancerIn: Laboratory Investigation, Jg. 101, 2021, Nr. 9, S. 1281 – 1288DOI (Open Access)
-
Botulinum Toxin A in Pediatric Day-Time Lower Urinary Tract Conditions : A Single Center ExperienceIn: Journal of Urology and Renal Diseases, Jg. 6, 2021, Nr. 6, 1236DOI (Open Access)
-
Correction to: : A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancerIn: Laboratory Investigation, Jg. 101, 2021, Nr. 10, S. 1414DOI (Open Access)
-
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranosticsIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2021, S. 385 – 389DOI (Open Access)
-
High serum pd-l1 levels are associated with poor survival in urothelial cancer patients treated with chemotherapy and immune checkpoint inhibitor therapyIn: Cancers, Jg. 13, 2021, Nr. 11, 2548DOI, Online Volltext (Open Access)
-
Implementation of radioguided surgery in prostate cancerIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 65, 2021, Nr. 3, S. 202 – 214
-
Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfallsIn: Translational Andrology and Urology, Jg. 10, 2021, Nr. 10, S. 3972 – 3985DOI (Open Access)
-
The value of an additional scrotal suture during orchidopexyIn: Journal of Pediatric Urology, Jg. 17, 2021, Nr. 1, S. 82.e1 – 82.e5
-
First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 13, S. 3194 – 3195
-
Genauigkeit der multiparametrischen MRT der Prostata zur Detektion eines klinisch-signifikanten ProstatakarzinomsIn: Der Urologe, Jg. 59, 2020, Nr. 1, S. 72 – 77
-
Nuclear Localization of Robo is Associated with Better Survival in Bladder CancerIn: Pathology & Oncology Research, Jg. 26, 2020, Nr. 1, S. 253 – 261
-
Renal duplication with ureter duplex not following Meyer-Weigert-Rule with development of a megaureter of the lower ureteral segment due to distal stenosis – A case reportIn: Urology Case Reports, Jg. 28, 2020, 101038DOI (Open Access)
-
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer PatientsIn: Pathology & Oncology Research, Jg. 26, 2020, Nr. 2, S. 1243 – 1249
-
Soluble syndecan-1 levels are associated with survival in platinum-treated bladder cancer patientsIn: Diagnostics, Jg. 10, 2020, Nr. 11, 864DOI, Online Volltext (Open Access)
-
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancerIn: Urologic Oncology: Seminars and Original Investigations, Jg. 37, 2019, Nr. 11, S. 810.e7 – 810.e15
-
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder : A Comprehensive Review Supplemented by Own DataIn: Disease Markers, 2018, 7308168DOI (Open Access)
-
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate CancerIn: Urologia Internationalis, Jg. 101, 2018, Nr. 1, S. 65 – 73
-
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancerIn: Pathology International, Jg. 67, 2017, Nr. 12, S. 597 – 601
-
Aktuelle Empfehlungen zum Management des NierentraumasIn: Der Urologe, Jg. 55, 2016, Nr. 8, S. 1095 – 1096
-
Lymphadenektomie beim Nebennierenrindenkarzinom : Kann die krankheitsspezifische Mortalität gesenkt werden?In: Der Urologe, Jg. 55, 2016, Nr. 4, S. 524
-
A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?In: European Urology. Amsterdam: Elsevier, Jg. 85, 2024, Nr. 3, S. 227 – 228
-
Improving radical prostatectomy with intraoperative ex-vivo PSMA-PET/CT imaging
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S586 -
Intraoperative microPET/CT imaging for PSMA-positive cancer foci in radical prostatectomy – feasibility study
38th Annual EAU (European Association of Urology) Congress ; EAU23 ; 10 - 13 March 2023, Milan, Italy,In: European Urology. Amsterdam: Elsevier, Jg. 83, 2023, Nr. Supplement 1, S. S687 -
Molecular analysis of urothelial carcinoma to predict the efficacy of immune checkpoint inhibitor therapy
38th Annual European Association of Urology Congress (EAU) ; March 10 - 13, 2023, Milan, Italy,In: European Urology. Amsterdam: Elsevier, Jg. 83, 2023, Nr. Supplement 1: Abstracts EAU23, S. S1679 – S1680 -
Online-adaptive Strahlentherapie beim muskelinvasiven Blasenkarzinom mit angepassten PTVSäumen : Vorteil gegenüber der IGRT zum Zeitpunkt der Adaptation und gute akkumulierte EUD zum Zeitpunkt der ApplikationIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S153DOI (Open Access)
-
Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging/transrectal ultrasonography-fusion biopsy : A prospective, randomized comparison to conventional target biopsy
EAU21 Virtual Congress; 8-12 July 2021; Virtual,In: European Urology. Amsterdam: Elsevier, Jg. 79, 2021, Nr. Suppl. 1, S. S1272 -
Preliminary Investigations on Radiation Exposure in [68Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S212DOI (Open Access) -
Identifikation molekularer Biomarker beim fortgeschrittenen Urothelkarzinom der HarnblaseDuisburg ; Essen, 2022
-
A randomized phase I/II study of neoadjuvant treatment with ¹⁷⁷-Lutetium-PSMA-617 with or without ipilimumab in patients with very high-risk prostate cancer who are candidates for radical prostatectomy (NEPI trial)
2024 ASCO Genitourinary Cancers Symposium, January 25 - 27, 2024, San Francisco, CA, USA,In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, TPS352